Skip to main content
SpringerLink
Log in

Efavirenz: incidence of CNS and psychiatric disorders in Uganda

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Seden K, et al. High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily. Journal of Antimicrobial Chemotherapy : Aug 2018. Available from: URL: http://doi.org/10.1093/jac/dky298

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Efavirenz: incidence of CNS and psychiatric disorders in Uganda. Reactions Weekly 1716, 11 (2018). https://doi.org/10.1007/s40278-018-50809-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-50809-9

Search

Navigation